BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17290394)

  • 1. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk.
    Wu X; Lin J; Etzel CJ; Dong Q; Gorlova OY; Zhang Q; Amos CI; Spitz MR
    Int J Cancer; 2007 Jun; 120(12):2687-95. PubMed ID: 17290394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.
    Strom SS; Wu S; Sigurdson AJ; Hsu TC; Fueger JJ; Lopez J; Tee PG; Spitz MR
    J Natl Cancer Inst Monogr; 1995; (18):29-33. PubMed ID: 8562219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
    Wu X; Yu H; Amos CI; Hong WK; Spitz MR
    J Natl Cancer Inst; 2000 May; 92(9):737-43. PubMed ID: 10793110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
    Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
    J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagen sensitivity as a marker of cancer susceptibility.
    Spitz MR; Wu X; Jiang H; Hsu TC
    J Cell Biochem Suppl; 1996; 25():80-4. PubMed ID: 9027602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans.
    Spitz MR; Hsu TC; Wu X; Fueger JJ; Amos CI; Roth JA
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):99-103. PubMed ID: 7537995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
    Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
    Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.
    Wu X; Hsu TC; Cao S; Lee JJ; Amos CI; Spitz MR
    Carcinogenesis; 1998 Jan; 19(1):93-8. PubMed ID: 9472699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
    Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three measures of mutagen sensitivity in a cancer-free population.
    Gu J; Bondy ML; Sigurdson A; Spitz MR; Hsu TC; Wu X
    Cancer Genet Cytogenet; 1999 Apr; 110(1):65-9. PubMed ID: 10198626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a genetic basis for lung cancer susceptibility?
    Amos CI; Xu W; Spitz MR
    Recent Results Cancer Res; 1999; 151():3-12. PubMed ID: 10337715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
    Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
    Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
    Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers.
    Leng S; Stidley CA; Bernauer AM; Picchi MA; Sheng X; Frasco MA; Van Den Berg D; Gilliland FD; Crowell RE; Belinsky SA
    Carcinogenesis; 2008 Jul; 29(7):1380-5. PubMed ID: 18499700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk.
    Wu X; Delclos GL; Annegers JF; Bondy ML; Honn SE; Henry B; Hsu TC; Spitz MR
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):583-8. PubMed ID: 8547823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.
    Wu X; Shi H; Jiang H; Kemp B; Hong WK; Delclos GL; Spitz MR
    Carcinogenesis; 1997 May; 18(5):967-73. PubMed ID: 9163682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer.
    Wu X; Gu J; Dong Q; Huang M; Do KA; Hong WK; Spitz MR
    Clin Cancer Res; 2006 Dec; 12(23):7194-201. PubMed ID: 17145846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.